Details for New Drug Application (NDA): 201089
✉ Email this page to a colleague
The generic ingredient in DICLOFENAC SODIUM AND MISOPROSTOL is diclofenac sodium; misoprostol. There are forty-seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the diclofenac sodium; misoprostol profile page.
Summary for 201089
| Tradename: | DICLOFENAC SODIUM AND MISOPROSTOL |
| Applicant: | Actavis Labs Fl Inc |
| Ingredient: | diclofenac sodium; misoprostol |
| Patents: | 0 |
Pharmacology for NDA: 201089
| Mechanism of Action | Cyclooxygenase Inhibitors |
| Physiological Effect | Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 201089
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DICLOFENAC SODIUM AND MISOPROSTOL | diclofenac sodium; misoprostol | TABLET, DELAYED RELEASE;ORAL | 201089 | ANDA | Actavis Pharma, Inc. | 0591-0397 | 0591-0397-19 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0591-0397-19) |
| DICLOFENAC SODIUM AND MISOPROSTOL | diclofenac sodium; misoprostol | TABLET, DELAYED RELEASE;ORAL | 201089 | ANDA | Actavis Pharma, Inc. | 0591-0397 | 0591-0397-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0591-0397-60) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 50MG;0.2MG | ||||
| Approval Date: | Jul 9, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 75MG;0.2MG | ||||
| Approval Date: | Jul 9, 2012 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
